What is Guillain-Barre?

Guillain-Barré syndrome (GBS) is a rare neurological disorder in which the body's immune system attacks the nerves. This leads to weakness and numbness in the legs and arms, and can eventually cause paralysis. GBS is thought to be triggered by a bacterial or viral infection.

Symptoms of Guillain-Barré syndrome

The symptoms of GBS can vary from person to person, but they typically develop over a period of days or weeks. The most common symptoms include:

* Weakness and numbness in the legs and arms

* Tingling or prickling sensations in the hands and feet

* Difficulty walking

* Difficulty speaking or swallowing

* Blurred vision

* Drooping eyelids

* Fatigue

* Difficulty breathing

Diagnosis of Guillain-Barré syndrome

GBS is diagnosed based on the person's symptoms and a physical examination. The doctor may also order tests, such as a nerve conduction study or a spinal tap, to confirm the diagnosis.

Treatment for Guillain-Barré syndrome

There is no cure for GBS, but treatment can help to improve symptoms and speed up recovery. Treatment may include:

* Plasmapheresis (plasma exchange): This is a procedure in which blood is removed from the body, the plasma is separated from the red blood cells, and the plasma is then replaced with a salt solution.

* Intravenous immunoglobulin (IVIg): This is a treatment in which antibodies are given to the person through a vein.

* Corticosteroids: These are medications that help to reduce inflammation.

* Supportive care: This may include measures such as providing respiratory support, preventing blood clots, and managing pain.

Recovery from Guillain-Barré syndrome

The recovery from GBS can be long and challenging. Most people with GBS will eventually recover, but it can take months or even years. Some people may experience permanent weakness or numbness.

Prognosis of Guillain-Barré syndrome

The prognosis of GBS depends on the severity of the symptoms and the person's overall health. Most people with GBS will eventually recover, but some people may experience permanent weakness or numbness. The mortality rate for GBS is about 5%.